Abstract 80: The Experimental Neuroprotective Drug Na1 Does Not Interfere With the Fibrinolytic Activities of Alteplase or Tenecteplase
Sign Up to like & getrecommendations! Published in 2019 at "Stroke"
DOI: 10.1161/str.50.suppl_1.80
Abstract: Introduction: Tissue plasminogen activator (Alteplase; tPA) is the most commonly used thrombolytic medication for treatment of acute ischemic stroke, and recent research suggests that Tenecteplase ... read more here.
Keywords: na1 interfere; tenecteplase; abstract experimental; neuroprotective drug ... See more keywords
Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2022.917867
Abstract: Background Recent studies have reported that pulmo-neurotropic viruses can cause systemic invasion leading to acute respiratory failure and neuroinfection. The tetracycline class of secondary metabolites of microorganisms is effective against several migrating neurotropic viral disorders,… read more here.
Keywords: drug discovery; systems biology; infection; biology ... See more keywords